Interview Spotlights
Valuable insights from experts
Q&A: Mental health conditions underrecognized in patients with AMD
Healio spoke with Aleksandra Rachitskaya, MD, a vitreoretinal surgeon and associate professor of ophthalmology at Cleveland Clinic Cole Eye Institute, about mental health conditions in patients with age-related macular degeneration.
Q&A: Understanding the impact of socioeconomic disparities in AMD
Healio spoke with Bradley Dougherty, OD, PhD, associate professor at The Ohio State University College of Optometry, about how socioeconomic factors can affect the diagnosis, treatment and outcomes of age-related macular degeneration.
Q&A: Stem cell patch aims to improve AMD vision loss
There are no current therapies to improve vision in patients with advanced age-related macular degeneration, but research on the safety of a stem cell patch has indicated positive results in patients suffering from vision loss, according to researchers.
AMD highlights from ASRS: Positive real-world faricimab data, gene therapy and more
The American Society of Retina Specialists annual meeting featured study results and research in age-related macular degeneration.
‘You are what you eat’: How healthy eating and living can benefit eyes, lower AMD risk
The link between nutrition and ocular health became apparent in the early 1990s as epidemiologists and ophthalmologists uncovered dietary patterns in patients with AMD.
Q&A: State of diagnosis, screening in AMD
Earlier diagnosis of certain types of age-related macular degeneration is integral to preserve vision for patients.
Modifiable risk factors for AMD the same for women, men
Women appear to have a higher risk for developing age-related macular degeneration, but the reason for this remains unclear, according to Rishi P. Singh, MD.
Remote AMD monitoring leads to more personalized care
Age-related macular degeneration is a condition that requires regular monitoring in order to preserve vision and detect any changes in the eye.
Biosimilars to expand AMD treatment options
As novel treatment options, including biosimilars, for age-related macular degeneration emerge, it has become a “fascinating time to practice,” according to Aleksandra Rachitskaya, MD.
AI revolutionizing AMD diagnosis, treatment
As COVID-19 ushered telemedicine and virtual visits to the forefront of clinical practice, artificial intelligence has emerged as an important way to augment care.